ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 472.3 | 419.8 | 535.9 |
| Other income | 4.4 | 2.8 | 3.3 |
| Total income | 476.7 | 422.6 | 539.2 |
| Profit before exceptional items & tax | 137.9 | 83.0 | 165.3 |
| Profit before tax | 137.9 | 83.0 | 165.3 |
| Net profit | 102.6 | 61.7 | 119.5 |
| Operating margin | 28.9% | 19.6% | 30.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -14.10% |
|---|---|
| Net profit, quarter on quarter | +66.30% |
| Revenue, year on year | -11.90% |
NSE results filing, NSE: SANOFI. Figures extracted from the filing.
Sanofi India Ltd: key numbers
- Share price
- ₹3,282.10
- Market cap
- ₹7,559 Cr
- Revenue (annual)
- ₹1,837 Cr
- Net profit (annual)
- ₹326.7 Cr
- P/E (TTM)
- 20.7×Sector 43.8×
- Promoter holding
- 60.40%+0.00% QoQ
- FII holding
- 5.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanofi India Ltd
All →Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Sanofi India Dividend
Sanofi India declared an interim dividend of Rs 75 per equity share at its 29-Oct-2026 board meeting. Record date is 5-Nov-2026.
Sanofi India Q2 FY27 Results: Net Profit ₹116.7 Cr, Up 53.6% YoY
Sanofi India reported unaudited Q3 and nine-month results to 30 September 2026, with profit before tax up 22% to INR 158 crore. It also declared an interim dividend of Rs 75 per share with a record date of 5 November 2026.
- Key figure
- Net profit ₹116.7 Cr · +53.6% YoY
Sanofi India Other Announcement
Sanofi India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Sanofi India Board Meeting Date
Sanofi India will hold a board meeting on 29th October 2026 to consider unaudited financial results and a potential interim dividend for FY 2026.
Sanofi India Promoter Buying (Off-Market): ₹1,068 Cr
Sanofi Healthcare India acquired 3.5 million shares (15.20%) from Hoechst GmbH in a promoter-group block deal at ₹3,052/share. Total promoter stake unchanged at 60.40%.
- Value
- ₹1,068 Cr
- Promoter stake change
- +15.20%